A-84861

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameA-84861
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGonadotropin-releasing hormone receptor antagonists
TargetsGonadotropin-releasing hormone receptor
Therapy Area/IndicationsInfertility, FemaleInfertility, MaleProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTap Pharmaceutical Products IncAbbott LaboratoriesTakeda Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsInfertility, FemaleInfertility, MaleProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A